Report cover



The Safety, Efficacy, and Cost Effectiveness of Therapeutic Apheresis
NTIS order #PB84-114842





Full Report ~7557K

. . . . .

Front Matter ~98K
Table of Contents ~26K

Chapters
1: Introduction and Summary ~48K
2: Apheresis: Definitions, Descriptions, and Developments ~86K
3: Scientific and Medical Aspects of Apheresis: Issues and Evidence ~115K
4: Cost Effectiveness and Reimbursement Policy: Issues and Evidence ~62K
5: Implications for Policy ~20K

Appendixes
A: Health Program Advisory Committee and Acknowledgments ~14K
B: Apheresis for Hemolytic-Uremic Syndrome ~39K
C: Apheresis for Inhibitors to Factor Vlll ~44K
D: Apheresis in Guillain-Barre Syndrome ~28K
E: The Cause and Pathological Development of Autoimmune Diseases ~7K
F: American Red Cross Bibliography ~6674K
References ~400K


Jump to: The OTA LegacyJump to: OTA & Congress
Jump to: OTA PublicationsJump to: About this site...